Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Study of Allogeneic Stem Cell Transplantation For Patients With Graft Failure Following Allogeneic Transplantation Using MHC Identical or Near Identical Donors and Submyeloablative Conditioning With CAMPATH 1H (CAMGRAFT)

NCT00048399 is registered in ClinicalTrials.gov with Baylor College of Medicine as lead sponsor.

NCT NCT00048399
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00048399 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Study of Allogeneic Stem Cell Transplantation For Patients With Graft Failure Following Allogeneic Transplantation Using MHC Identical or Near Identical Donors and Submyeloablative Conditioning With CAMPATH 1H (CAMGRAFT)
Lead sponsor
Baylor College of Medicine
Phase
Phase 1/2
Overall status
Terminated
Start date
December 31, 2000
Completion date
October 31, 2003
Enrollment
40
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

graft failure